We get a mention...

"Only one Long Haulers study using an investigational drug was completed—a trial for Long-COVID patients testing the monoclonal antibody, leronlimab, sponsored by Cytodyn (CYDY). Surprisingly, the results of the Long Covid trial were quite good and showed a clinically significant improvement in 18 out of 24 symptoms measured back in June 2021. There were reports that the company was waiting for FDA guidance regarding an approvable endpoint. "

https://www.zerohedge.com/news/2022-05-08/pfi...long-covid